Enriqueta Vallejo‐Yagüe

Cardiovascular Safety Profile of Romosozumab: A Pharmacovigilance Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS)

Annika Vestergaard Kvist, Junaid Faruque, Enriqueta Vallejo‐Yagüe et al. · Journal of Clinical Medicine · 2021 · 84 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Thromboembolic Safety Reporting of Tofacitinib and Baricitinib: An Analysis of the WHO VigiBase

Enriqueta Vallejo‐Yagüe, Stefan Weiler, Raphael Micheroli et al. · Drug Safety · 2020 · 51 citations

Medicine, Pharmacology, Pharmacotherapy +13

Sex and gender in infection and immunity: addressing the bottlenecks from basic science to public health and clinical applications

Chloé Pasin, Camila Rosat Consiglio, Jana S. Huisman et al. · Royal Society Open Science · 2023 · 20 citations · Full text

Social Sciences, Biomedical Sciences, Immunology +17

The Unseen Hand: AI-Based Prescribing Decision Support Tools and the Evaluation of Drug Safety and Effectiveness

Harriet Dickinson, Dana Y. Teltsch, Jan Feifel et al. · Drug Safety · 2023 · 19 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacotherapy +16

Minimal disease activity and remission in patients with psoriatic arthritis with elevated body mass index: an observational cohort study in the Swiss Clinical Quality Management cohort

Enriqueta Vallejo‐Yagüe, Theresa Burkard, Raphael Micheroli et al. · BMJ Open · 2022 · 18 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15